Literature DB >> 14711904

Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology.

Yigal Dror1, Eyal Grunebaum, Johann Hitzler, Aru Narendran, Charles Ye, Raymond Tellier, Vernon Edwards, Melvin H Freedman, Chaim M Roifman.   

Abstract

Purine nucleoside phosphorylase (PNP) deficiency is an autosomal recessive metabolic disorder characterized by severe combined immunodeficiency and by complex neurologic symptomatology including ataxia, developmental delay, and spasticity. Herein we report severe marrow dysplasia in a patient with PNP deficiency. Drug-related marrow dysfunction was unlikely, and marrow virological studies were negative. A preleukemic myelodysplastic syndrome was also unlikely due to normal marrow CD34+ cells, colony growth in clonogenic assay of marrow mononuclear cells, apoptosis rate, and Fas expression on marrow nucleated cells, as well as morphologic improvement of the marrow dysplasia after normal red blood cell transfusion. The patient's marrow stroma showed hypersensitivity to irradiation and undetectable PNP enzyme activity similar to peripheral lymphocytes. This is the first report of PNP deficiency associated with increased lymphocyte and marrow stromal sensitivity to irradiation. We conclude that marrows from patients with PNP deficiency might have hypersensitivity to irradiation and can develop dysplastic morphology, caused either directly or indirectly by the inherited enzymatic defect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14711904     DOI: 10.1203/01.PDR.0000111286.23110.F8

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  9 in total

1.  Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report.

Authors:  Barbara C Engel; Greg M Podsakoff; Joanna L Ireland; E Monika Smogorzewska; Denise A Carbonaro; Kathy Wilson; Ami Shah; Neena Kapoor; Mirna Sweeney; Mark Borchert; Gay M Crooks; Kenneth I Weinberg; Robertson Parkman; Howard M Rosenblatt; Shi-Qi Wu; Michael S Hershfield; Fabio Candotti; Donald B Kohn
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

2.  Novel Genetic Mutations in the First Swedish Patient with Purine Nucleoside Phosphorylase Deficiency and Clinical Outcome After Hematopoietic Stem Cell Transplantation with HLA-Matched Unrelated Donor.

Authors:  Nicholas Brodszki; Maria Svensson; André B P van Kuilenburg; Judith Meijer; Lida Zoetekouw; Lennart Truedsson; Jacek Toporski
Journal:  JIMD Rep       Date:  2015-05-13

3.  Purine nucleoside phosphorylase deficiency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons.

Authors:  Michael Tsui; Jeremy Biro; Jonathan Chan; Weixian Min; Kerry Dobbs; Luigi D Notarangelo; Eyal Grunebaum
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

4.  Purine nucleoside phosphorylase deficiency presenting as severe combined immune deficiency.

Authors:  Raz Somech; Atar Lev; Galia Grisaru-Soen; Shelly I Shiran; Amos J Simon; Eyal Grunebaum
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

5.  Purine nucleoside phosphorylase deficiency with fatal course in two sisters.

Authors:  Caner Aytekin; Figen Dogu; Gonul Tanir; Deniz Guloglu; Ines Santisteban; Michael S Hershfield; Aydan Ikinciogullari
Journal:  Eur J Pediatr       Date:  2009-08-06       Impact factor: 3.183

6.  The Broad Clinical Spectrum and Transplant Results of PNP Deficiency.

Authors:  Polina Stepensky; Irina Zaidman; Yael Dinur Schejter; Ehud Even-Or; Bella Shadur; Adeeb NaserEddin
Journal:  J Clin Immunol       Date:  2019-11-09       Impact factor: 8.542

7.  Intergenerational and intrafamilial phenotypic variability in 22q11.2 deletion syndrome subjects.

Authors:  Emilia Cirillo; Giuliana Giardino; Vera Gallo; Pamela Puliafito; Chiara Azzari; Rosa Bacchetta; Fabio Cardinale; Maria Pia Cicalese; Rita Consolini; Silvana Martino; Baldassarre Martire; Cristina Molinatto; Alessandro Plebani; Gioacchino Scarano; Annarosa Soresina; Caterina Cancrini; Paolo Rossi; Maria Cristina Digilio; Claudio Pignata
Journal:  BMC Med Genet       Date:  2014-01-02       Impact factor: 2.103

Review 8.  Gene therapy for severe combined immunodeficiency: are we there yet?

Authors:  Marina Cavazzana-Calvo; Alain Fischer
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

9.  Partial Purine Nucleoside Phosphorylase Deficiency Helps Determine Minimal Activity Required for Immune and Neurological Development.

Authors:  Eyal Grunebaum; Nicholas Campbell; Matilde Leon-Ponte; Xiaobai Xu; Hugo Chapdelaine
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.